-
Loading metrics
Validation of the motion sickness severity scale: Secondary analysis of a randomized, double-blind, placebo-controlled study of a treatment for motion sickness
-
Mark É. Czeisler ,
Roles Formal analysis, Writing – original draft, Writing – review & editing
* E-mail: Mark.Czeisler@Fulbrightmail.org (MÉC); Vasilios.Polymeropoulos@vandapharma.com (VMP)
Affiliation Vanda Pharmaceuticals, Washington, DC, United States of America
⨯ -
Justina M. Pruski,
Roles Writing – original draft, Writing – review & editing
Affiliation Vanda Pharmaceuticals, Washington, DC, United States of America
⨯ - Pan Wang,
- Jingyuan Wang,
- Changfu Xiao,
- Mihael H. Polymeropoulos,
- Vasilios M. Polymeropoulos
https://orcid.org/0000-0003-3100-7347
Validation of the motion sickness severity scale: Secondary analysis of a randomized, double-blind, placebo-controlled study of a treatment for motion sickness
- Mark É. Czeisler,
- Justina M. Pruski,
- Pan Wang,
- Jingyuan Wang,
- Changfu Xiao,
- Mihael H. Polymeropoulos,
- Vasilios M. Polymeropoulos
x
- Published: January 5, 2023
- https://doi.org/10.1371/journal.pone.0280058